PDF herunterladen
Ernährung & Medizin 2015; 30(02): 74-77
DOI: 10.1055/s-0034-1384470
wissen
Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart

Gicht

Purin-Punkte-Panik und Leitlinien-Irrsinn
Matthias Bastigkeit
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
02. Juli 2015 (online)

    Lizenzen und Reprints

Zusammenfassung

In den letzten 40 Jahren gab es kaum neue Erkenntnisse zur Gicht. Es erscheint, verglichen mit anderen Stoffwechselerkrankungen, undenkbar, dass es bis vor 3 Jahren nur ein einziges Medikament (!) zur Harnsäuresenkung gab. Doch in den letzten Jahren ist das Wissen zur Pathogenese und Therapie immens angestiegen. Der Fortschritt ist so rasant, dass Laborparameter, Leitlinien und Fachinformationen dem State of the Art hinterherhinken.

 

  • Literatur

  • 1 Arromdee E, Michet CJ, Crowson CS et al. Epidemiology of gout: is the incidence rising? J Rheumatol. 2002; 29: 2403-2406
    PubMedGoogle Scholar
  • 2 Becker MA, Schumacher HR Jr, Wortmann RL et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005; 353: 2450-2461
    CrossrefPubMedGoogle Scholar
  • 3 Choi HK, Atkinson K, Karlson EW et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004; 363: 1277-1281
    CrossrefPubMedGoogle Scholar
  • 4 Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008; 336: 309-312
    CrossrefPubMedGoogle Scholar
  • 5 Choi HK, Gao X, Curhan G. Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med 2009; 169: 502-507
    CrossrefPubMedGoogle Scholar
  • 6 Choi HK, Willett W, Curhan G. Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum 2007; 56: 2049-2055
    CrossrefPubMedGoogle Scholar
  • 7 Johnson RJ, Segal MS, Sautin Y et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007; 86: 899-906
    PubMedGoogle Scholar
  • 8 Johnson RJ, Feig DI, Herrera-Acosta J, Kang DH. Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 2005; 45: 18-20
    CrossrefPubMedGoogle Scholar
  • 9 Lottmann K, Chen X, Schadlich PK. Association between gout and all-cause as well as cardiovascular mortality: a systematic review. Curr Rheumatol Rep 2012; 14: 195-203
    CrossrefPubMedGoogle Scholar
  • 10 Schmidt JA, Crowe FL, Appleby PN et al. Serum uric acid concentrations in meat eaters, fish eaters, vegetarians and vegans: a cross-sectional analysis in the EPIC-Oxford cohort. PLOS one 2013; 8: e56339
    PubMedGoogle Scholar
  • 11 Schumacher HR Jr, Becker MA, Wortmann RL et al. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Rheum 2008; 59: 1540-1548
    CrossrefPubMedGoogle Scholar
  • 12 Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010; 90: 23-46
    PubMedGoogle Scholar